The False Promise of Single-Payer Health Care - Pipes, Sally C.
7,49 €
inkl. MwSt.

Versandfertig in über 4 Wochen
payback
4 °P sammeln
  • Broschiertes Buch

A government takeover of the US health care system has never looked more plausible. Support for the idea is at an all-time high. Two-thirds of Democratic voters favor "single-payer" health care; even one in four Republicans is on board. In this Broadside, Sally C. Pipes makes the case against single-payer by offering evidence of its devastating effects on patients in Canada, the United Kingdom, and even the United States. Long wait times, substandard care, lack of access to innovative treatments, huge public outlays, and spiraling costs are endemic to single-payer. Those are hardly outcomes we…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A government takeover of the US health care system has never looked more plausible. Support for the idea is at an all-time high. Two-thirds of Democratic voters favor "single-payer" health care; even one in four Republicans is on board. In this Broadside, Sally C. Pipes makes the case against single-payer by offering evidence of its devastating effects on patients in Canada, the United Kingdom, and even the United States. Long wait times, substandard care, lack of access to innovative treatments, huge public outlays, and spiraling costs are endemic to single-payer. Those are hardly outcomes we should consider foisting upon the American health care system.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Sally C. Pipes is president and CEO of the Pacific Research Institute, a San Francisco-based think tank, and the Thomas W. Smith Fellow in Health Care Policy at PRI.  She previously served as assistant director of Canada's Fraser Institute.  She is the author of The Way Out of Obamacare (Encounter 2015); The Cure for Obamacare (Encounter 2013); The Pipes Plan (Regnery 2012); and The Truth About Obamacare (Regnery 2010). Ms. Pipes also writes bi-weekly columns for Forbes.com and Investor's Business Daily , and blogs for the Washington Examiner.